Viagen Pets and Equine is a biotechnology company that will produce genetic twins of customers' pets and livestock. But its conservation efforts are what attracted Colossal.
How they’re doing it: The new company, called Preventive, is being formed to research so-called “heritable genome editing,” ...
Although heart cells and skin cells contain identical instructions for creating proteins encoded in their DNA, they're able ...
Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...
In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...
Colossal’s purchase of ViaGen, known for cloning pets of celebrities, bolsters the biotech firm’s tools for de-extinction and ...
Live Science on MSNOpinion
One molecule could usher revolutionary medicines for cancer, diabetes and genetic disease — but the US is turning its back on it
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
CAR T and CAR Treg therapies revolutionize cancer treatment through automation, scalability, and global manufacturing innovation.
Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced today that they entered into a exclusive license agreement ...
The grantmaking organization Open Philanthropy has awarded funding for a University of California San Diego technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback